SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
BioAlliance Pharma: First Meeting of the DSMB of the ReLive Trial and Continuation Without Modification of the Phase III Clinical Trial With Livatag® in Primary Liver Cancer